Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Recruiting now
Conditions studied: Gastric Cancer, Atrophic Gastritis, Gastric Dysplasia, H.Pylori Infection
In brief
The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.
Key facts
- Study ID
- NCT04022109
- Run by
- University of Latvia
- People needed
- 5000
- Starts
- 2019-11-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2021-07-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with verified gastric cancer (Group 1 \& 2)
- Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
- Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
- Motivation to participate in the study
- Physical status allowing volatile marker sampling and other procedures within the protocol
- Signed consent
You may not qualify if…
- Known other active cancer
- Ventilation problems, airway obstruction
- Unwillingness or inability to co-operate
Where it is running
- A.C.Camargo Cancer Center — São Paulo, Brazil (enrolling)
- Institute of Clinical and Preventive Medicine, University of Latvia — Riga, Latvia (enrolling)
- National Cancer Institute of Ukraine — Kiev, Ukraine (enrolling)
- Pontificia Universidad Catolica de Chile — Santiago, Chile
- Centro Javeriano de Oncología, San Ignacio University Hospital — Bogotá, Colombia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.